| Janelle H Porter, PA-C | |
|
500 Blazier Dr Ste 200, Wexford, PA 15090-9508 | |
| (412) 359-8900 | |
| (412) 359-8977 |
| Full Name | Janelle H Porter |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 12 Years |
| Location | 500 Blazier Dr Ste 200, Wexford, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184067993 | NPI | - | NPPES |
| 12565703 | Other | CAQH | |
| 103682874 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | C05615 (Maryland) | Secondary |
| 363A00000X | Physician Assistant | MA062766 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allegheny Clinic | 5395649586 | 1941 |
News Archive
A new study suggests young people with a serious genetic blood disorder are not getting the right help at school, especially pupils who miss lessons due to sickness.
A research team's discovery of new information about how plants synthesize carotenoids, precursors for vitamin A that are essential for plant development and survival, and human health, could help scientists increase the levels of provitamin A in food crops and reduce global vitamin A deficiency.
A team of Spanish researchers have designed and validated a simulator to enable study of the evolution of the COVID-19 illness in Spain and in all Europe, based on parameters such as climate, social distancing policies and transportation.
PaxVax Corporation, developer of innovative and socially responsible oral vaccines against infectious diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for its single-dose oral cholera vaccine, clearing the way to begin clinical trials. The company intends to begin Phase 3 trials later this year.
Last year, a Wyss Institute team of scientists described the development of a new device to treat sepsis that works by mimicking our spleen. It cleanses pathogens and toxins from blood circulating through a dialysis-like circuit. Now, the Wyss Institute team has developed an improved device that synergizes with conventional antibiotic therapies and that has been streamlined to better position it for near-term translation to the clinic.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Janelle H Porter, PA-C 500 Blazier Dr Ste 200, Wexford, PA 15090-9508 Ph: (412) 359-8900 | Janelle H Porter, PA-C 500 Blazier Dr Ste 200, Wexford, PA 15090-9508 Ph: (412) 359-8900 |
News Archive
A new study suggests young people with a serious genetic blood disorder are not getting the right help at school, especially pupils who miss lessons due to sickness.
A research team's discovery of new information about how plants synthesize carotenoids, precursors for vitamin A that are essential for plant development and survival, and human health, could help scientists increase the levels of provitamin A in food crops and reduce global vitamin A deficiency.
A team of Spanish researchers have designed and validated a simulator to enable study of the evolution of the COVID-19 illness in Spain and in all Europe, based on parameters such as climate, social distancing policies and transportation.
PaxVax Corporation, developer of innovative and socially responsible oral vaccines against infectious diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for its single-dose oral cholera vaccine, clearing the way to begin clinical trials. The company intends to begin Phase 3 trials later this year.
Last year, a Wyss Institute team of scientists described the development of a new device to treat sepsis that works by mimicking our spleen. It cleanses pathogens and toxins from blood circulating through a dialysis-like circuit. Now, the Wyss Institute team has developed an improved device that synergizes with conventional antibiotic therapies and that has been streamlined to better position it for near-term translation to the clinic.
› Verified 8 days ago
Victoria Ryan, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 7000 Stonewood Dr Ste 151, Wexford, PA 15090 Phone: 724-933-0300 | |
Devin Leigh Petit, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 11279 Perry Hwy, Wexford, PA 15090 Phone: 412-692-7337 | |
Andrea Blakemore, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 12311 Perry Hwy, Wexford, PA 15090 Phone: 877-660-6777 Fax: 412-359-8055 | |
Hunter Anderson Baxter, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 9000 Brooktree Rd Ste 200, Wexford, PA 15090 Phone: 412-647-4200 | |
Jennifer L Clark, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 7500 Brooktree Rd, Wexford, PA 15090 Phone: 412-367-0600 | |
Nicholas Jude Fleisner, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 7500 Brooktree Rd, Wexford, PA 15090 Phone: 866-874-7483 | |
Lisa Wood, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Stonewood Dr Ste 200, Suite 200, Wexford, PA 15090 Phone: 724-934-5520 |